Skip to main content

Table 2 Risk factor, past history, the location of AMI and medication in different group

From: Effect of haemoglobin concentration on the clinical outcomes in patients with acute myocardial infarction and the factors related to haemoglobin

Variable

<100 g/L

(n = 86)

101-110 g/L

(n = 74)

111-120 g/L

(n = 143)

121-130 g/L

(n = 222)

131-140 g/L

(n = 278)

141-150 g/L

(n = 296)

151-160 g/L

(n = 173)

>160 g/L

(n = 122)

p value

Past history

         

Hypertension(%)

61 (70.9)

46 (62.2)

79 (55.2)

124 (55.9)

143 (51.4)

159 (53.7)

88 (50.9)

65 (53.3)

0.064

Diabetes mellitus(%)

40 (46.5)

19 (25.7)

48 (33.6)

64 (28.8)

58 (20.9)

52 (17.6)

32 (18.5)

18 (14.8)

0.000

Hyperlipidemia(%)

27 (31.8)

29 (39.1)

39 (27.4)

76 (34.2)

111 (39.9)

142 (47.9)

99 (57.0)

74 (60.7)

0.000

CAD(%)

36 (41.9)

28 (37.8)

50 (35.0)

74 (33.3)

69 (24.8)

81 (27.4)

34 (19.7)

30 (24.6)

0.001

Smoking history(%)

16 (18.6)

20 (27.0)

45 (31.5)

71 (32.0)

144 (51.8)

138 (46.6)

97 (56.1)

71 (58.2)

0.000

Family history of CHD(%)

13 (15.1)

16 (21.6)

26 (18.2)

54 (24.3)

78 (28.1)

97 (32.8)

55 (31.8)

38 (31.1)

0.003

Location of AMI

         

Anterior wall(%)

21 (24.4)

25 (33.8)

45 (31.5)

75 (33.8)

98 (35.3)

123 (41.6)

69 (39.9)

55 (45.1)

0.025

Inferior wall(%)

18 (20.9)

26 (35.1)

46 (32.2)

57 (25.7)

98 (35.3)

100 (33.8)

53 (30.6)

36 (29.5)

0.129

Other wall(%)

9 (10.5)

9 (12.2)

14 (9.8)

26 (11.7)

35 (19.9)

43 (14.5)

21 (12.1)

24 (19.7)

0.356

Non-Q wave MI(%)

38 (44.2)

22 (29.7)

39 (27.3)

71 (32.0)

69 (24.8)

53 (17.9)

31 (17.9)

25 (20.5)

0.000

Indexed medication

         

Aspirin(%)

59 (68.6)

58 (78.4)

128 (89.5)

203 (91.4)

250 (89.9)

280 (94.6)

164 (94.8)

113 (92.6)

0.000

β-blocker(%)

46 (53.5)

34 (45.9)

69 (48.3)

125 (56.3)

181 (65.1)

187 (63.2)

104 (60.1)

72 (59.0)

0.005

CCB(%)

22 (25.6)

17 (23.0)

46 (47.4)

46 (20.7)

60 (21.6)

71 (24.0)

38 (22.0)

27 (22.1)

0.322

Nitrates(%)

62 (72.1)

52 (70.3)

116 (81.1)

162 (73.0)

207 (74.5)

207 (69.9)

115 (66.5)

86 (70.5)

0.170

ACEI(%)

44 (51.2)

39 (52.7)

74 (51.7)

111 (50.0)

156 (56.1)

179 (60.5)

110 (63.6)

69 (56.6)

0.104

ARB(%)

6 (7.0)

5 (6.8)

8 (5.6)

11 (5.0)

13 (4.7)

19 (6.4)

9 (5.2)

7 (5.7)

0.981

Statin(%)

25 (29.1)

23 (31.1)

57 (39.9)

98 (44.1)

128 (46.0)

160 (54.1)

92 (53.2)

68 (55.7)

0.000

Thrombolysis(%)

4 (4.7)

6 (8.1)

10 (7.0)

27 (12.2)

40 (14.4)

56 (18.9)

27 (15.6)

20 (16.4)

0.002

Anticoagulation(%)

47 (54.7)

42 (56.8)

84 (58.7)

133 (59.9)

179 (64.4)

185 (62.5)

113 (65.3)

87 (71.3)

0.198

PCI(%)

20 (23.3)

33 (44.6)

48 (33.6)

120 (54.1)

178 (64.0)

231 (78.0)

145 (83.8)

93 (76.2)

0.000

  1. CAD: coronary artery disease; CHD: coronary heart disease; CCB: calcium channel blockers; ACEI: ACE inhibitor; ARB: angiotensin receptor blocker; PCI: percutaneous coronary intervention. The numbers but those in the second line in parentheses are expressed in percentage.